No abstract available
Le Gouill, S., Dlugosz-Danecka, M., Rule, S., Zinzani, P.L., Goy, A., Smith, S.D., et al. (2024). Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors. HAEMATOLOGICA, 109(1), 343-350 [10.3324/haematol.2022.282469].
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
Zinzani P. L.;
2024
Abstract
No abstract availableFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
11166-Article Text-81551-2-10-20231227.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale (CCBYNC)
Dimensione
3.96 MB
Formato
Adobe PDF
|
3.96 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
